← Leaderboards
Kenneth Mark Coggeshall
Oklahoma Medical Research Foundation
$14,637,824
Attributed
$14,873,293
Total exposure
25
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.4M · FY2005–23$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$60,997,062 · 26
By mechanism
U19$57,014,084 · 17
R01$2,570,764 · 2
P20$941,276 · 6
R21$470,938 · 1
Top collaborators
- Florea Lupu2 shared
Most similar at Oklahoma Medical Research Foundation
Same institution · by research overlap
- A. Darise Farris$16,682,449
- Judith A James$55,525,870
- Carol F Webb$8,174,314
- Shinichiro Kurosawa$10,924,747
- Florea Lupu$19,062,937
Others in their field
Top investigators on “Anthrax Disease”
- Laurence Lemiale · Emergent Product Development Gaithersbur$61,222,506
- Daniel F. Hoft · Saint Louis University$26,271,892
- David Heimbrook · Leidos Biomedical Research, Inc.$21,781,988
- Donald S. Burke · Johns Hopkins University$21,607,962
- Michael E. Johnson · University Of Illinois At Chicago$19,502,736
- Alan Thomas Johnson · Hawaii Biotech, Inc.$17,292,079
Research focus
Anthrax DiseasePathogenMolecularImmunologicsBacillus AnthracisCellsImmuneResponseGrantInfectionImmune ResponsePapioBacillus Anthracis SporeNonhuman PrimatePeptidoglycanBiologicalFundingInflammationSepsisCytokineProductionCessation Of LifePathologyAnimals
Grant awards (84)
Complement and coagulation in B. anthracis peptidoglycan-induced sepsis$462,390
U19 · FY2023 · AI · contact PI
Administrative Core$132,098
U19 · FY2023 · AI · contact PI
Core-001$84,229
U19 · FY2023 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,226,563
U19 · FY2021 · AI · contact PI
Complement and coagulation in B. anthracis peptidoglycan-induced sepsis$454,480
U19 · FY2021 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$220,773
U19 · FY2021 · AI · contact PI
Administrative Core$157,320
U19 · FY2021 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,229,796
U19 · FY2020 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$916,783
U19 · FY2020 · AI · contact PI
Administrative Core$832,784
U19 · FY2020 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$832,784
U19 · FY2020 · AI · contact PI
Administrative Core$476,466
U19 · FY2020 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$476,466
U19 · FY2020 · AI · contact PI
Complement and coagulation in B. anthracis peptidoglycan-induced sepsis$456,075
U19 · FY2020 · AI · contact PI
Administrative Core$150,283
U19 · FY2020 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,267,196
U19 · FY2019 · AI · contact PI
Complement and coagulation in B. anthracis peptidoglycan-induced sepsis$454,480
U19 · FY2019 · AI · contact PI
Administrative Core$157,320
U19 · FY2019 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,898,581
U19 · FY2018 · AI · contact PI
Anti-Peptidoglycan Antibodies and Complement in Anthrax Pathogenesis$442,924
U19 · FY2018 · AI · contact PI
Administrative Core$148,941
U19 · FY2018 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,898,581
U19 · FY2017 · AI · contact PI
Anti-Peptidoglycan Antibodies and Complement in Anthrax Pathogenesis$431,000
U19 · FY2017 · AI · contact PI
Administrative Core$148,570
U19 · FY2017 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,898,581
U19 · FY2016 · AI · contact PI
Anti-Peptidoglycan Antibodies and Complement in Anthrax Pathogenesis$384,287
U19 · FY2016 · AI · contact PI
Anti-Peptidoglycan Antibodies and Complement in Anthrax Pathogenesis$225,590
U19 · FY2016 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax Infections$225,590
U19 · FY2016 · AI · contact PI
Administrative Core$141,419
U19 · FY2016 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,898,581
U19 · FY2015 · AI · contact PI
Anti-Peptidoglycan Antibodies and Complement in Anthrax Pathogenesis$435,696
U19 · FY2015 · AI · contact PI
Development of a mouse model of peptidoglycan-induced pathology$214,375
R21 · FY2015 · AI · contact PI
Administrative Core$164,514
U19 · FY2015 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,910,854
U19 · FY2014 · AI · contact PI
Anti-Peptidoglycan Antibodies and Complement in Anthrax Pathogenesis$372,221
U19 · FY2014 · AI · contact PI
Development of a mouse model of peptidoglycan-induced pathology$256,563
R21 · FY2014 · AI · contact PI
Administrative Core$163,777
U19 · FY2014 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,703,462
U19 · FY2013 · AI · contact PI
B. anthracis Peptidoglycan as a Pro-inflammatory Agent in Anthrax Pathogenesis$385,765
U19 · FY2013 · AI · contact PI
Administration Core$162,877
U19 · FY2013 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,776,772
U19 · FY2012 · AI · contact PI
B. anthracis Peptidoglycan as a Pro-inflammatory Agent in Anthrax Pathogenesis$241,536
U19 · FY2012 · AI · contact PI
Administration Core$134,504
U19 · FY2012 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,840,289
U19 · FY2011 · AI · contact PI
B. anthracis Peptidoglycan as a Pro-inflammatory Agent in Anthrax Pathogenesis$272,982
U19 · FY2011 · AI · contact PI
Administration Core$139,971
U19 · FY2011 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,991,269
U19 · FY2010 · AI · contact PI
B. anthracis Peptidoglycan as a Pro-inflammatory Agent in Anthrax Pathogenesis$287,104
U19 · FY2010 · AI · contact PI
Administration Core$147,437
U19 · FY2010 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,986,968
U19 · FY2009 · AI · contact PI
B. anthracis Peptidoglycan as a Pro-inflammatory Agent in Anthrax Pathogenesis$285,528
U19 · FY2009 · AI · contact PI
Administration Core$149,396
U19 · FY2009 · AI · contact PI
SIGNAL TRANSDUCTION CORE$72,303
P20 · FY2009 · RR · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Anthrax$2,616,353
U19 · FY2008 · AI · contact PI
Regulation of Macrophage Apoptosis by Anthrax Lethal Factor$285,477
U19 · FY2008 · AI · contact PI
Education Component$89,968
U19 · FY2008 · AI · contact PI
CORE: SIGNAL TRANSDUCTION CORE FACILITY$70,641
P20 · FY2008 · RR · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Anthrax$2,578,694
U19 · FY2007 · AI · contact PI
Regulation of Macrophage Apoptosis by Anthrax Lethal Factor$193,401
U19 · FY2007 · AI · contact PI
CORE: SIGNAL TRANSDUCTION CORE FACILITY$72,091
P20 · FY2007 · RR · contact PI
Education Component$60,942
U19 · FY2007 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Anthrax$2,728,833
U19 · FY2006 · AI · contact PI
Signaling by IgG receptors leading to phagocytosis$306,426
R01 · FY2006 · AI · contact PI
Regulation of Macrophage Apoptosis by Anthrax Lethal Factor$296,735
U19 · FY2006 · AI · contact PI
Education Component$93,513
U19 · FY2006 · AI · contact PI
CORE: SIGNAL TRANSDUCTION CORE FACILITY$74,263
P20 · FY2006 · RR · contact PI
Signaling by IgG receptors leading to phagocytosis$313,800
R01 · FY2005 · AI
Regulation of Macrophage Apoptosis by Anthrax Lethal Factor$296,723
U19 · FY2005 · AI
Education Component$93,509
U19 · FY2005 · AI
COBRE: CORE2: SIGNAL TRANSDUCTION CORE FACILITY$58,950
P20 · FY2005 · RR
Signaling by IgG receptors leading to phagocytosis$313,800
R01 · FY2004 · AI
Regulation of Macrophage Apoptosis by Anthrax Lethal Factor$301,172
U19 · FY2004 · AI
Education Component$94,911
U19 · FY2004 · AI
COBRE: CORE2: SIGNAL TRANSDUCTION CORE FACILITY$80,870
P20 · FY2004 · RR
Signaling by IgG receptors leading to phagocytosis$313,800
R01 · FY2003 · AI
PHOSPHATIDYLINOSITOL 3 KINASE IN B CELL ACTIVATION$266,402
R01 · FY2003 · CA
Signaling by IgG receptors leading to phagocytosis$313,800
R01 · FY2002 · AI
PHOSPHATIDYLINOSITOL 3 KINASE IN B CELL ACTIVATION$258,644
R01 · FY2002 · CA
Core--Signal transduction facility$0
P20 · FY2002 · RR
Core--Signal transduction facility$256,079
P20 · FY2001 · RR
PHOSPHATIDYLINOSITOL 3 KINASE IN B CELL ACTIVATION$251,112
R01 · FY2001 · CA
Core--Signal transduction facility$0
P20 · FY2001 · RR
Core--Signal transduction facility$256,079
P20 · FY2000 · RR
PHOSPHATIDYLINOSITOL 3 KINASE IN B CELL ACTIVATION$232,980
R01 · FY2000 · CA